---
title: "Jaguar Health completes FDA submission seeking full approval of Canalevia-CA1 for dog chemo diarrhea"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290567491.md"
description: "Jaguar Health has submitted a New Animal Drug Application to the FDA seeking full approval for Canalevia-CA1 (crofelemer) to treat chemotherapy-induced diarrhea in dogs. The drug currently holds conditional approval. The submission includes pivotal effectiveness study data showing statistically significant results, with 77% of owners reporting the treatment was effective."
datetime: "2026-06-23T13:01:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290567491.md)
  - [en](https://longbridge.com/en/news/290567491.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290567491.md)
generator: "portal-rs"
---

# Jaguar Health completes FDA submission seeking full approval of Canalevia-CA1 for dog chemo diarrhea

-   Jaguar Health completed submission of a New Animal Drug Application to the FDA’s Center for Veterinary Medicine for full approval of crofelemer in chemotherapy-induced diarrhea in dogs. \* Crofelemer, sold as Canalevia-CA1, currently holds conditional approval for the indication. \* Submission includes a pivotal effectiveness study showing statistically significant results, with 77% of owners reporting the treatment was effective. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606230900ACCESSWRNAPR\_\_\_\_\_1180236) on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [JAGX.US](https://longbridge.com/en/quote/JAGX.US.md)
- [ACCS.US](https://longbridge.com/en/quote/ACCS.US.md)

## Related News & Research

- [Jaguar Health provides crofelemer on compassionate-use basis for infant with intestinal failure due to congenital sodium diarrhea](https://longbridge.com/en/news/298038530.md)
- [Jaguar Health shareholder meeting fails for lack of quorum, won’t be reconvened](https://longbridge.com/en/news/298072349.md)
- [Jazz reports Phase III trial interim results for Ziihera combination](https://longbridge.com/en/news/298029886.md)
- [Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) | JAGX Stock News](https://longbridge.com/en/news/298040982.md)
- [Health Rounds: Psychedelic drug shows promise for preventing chemotherapy-induced nerve damage](https://longbridge.com/en/news/297960476.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**